Form 4 Filing for Replimune Group, Inc. - Officer/Director Transaction

This Form 4 filing pertains to Replimune Group, Inc. (REPL) and details a transaction by Dieter Weinand, a director. The transaction, dated April 1, 2026, involves the acquisition of 44,500 Stock Options with a right to buy Common Stock. The options have an exercise price of $7.61 and an expiration date of April 1, 2036. The underlying securities amount to 44,500 shares. The filing notes that this Form 4 is being submitted late due to an inadvertent administrative error. The shares underlying the option vest entirely on April 1, 2027. This filing is classified as an Officer/Director transaction.